To The Moon
Home
News
TigerAI
Log In
Sign Up
barristars
+Follow
Posts · 57
Posts · 57
Following · 0
Following · 0
Followers · 0
Followers · 0
barristars
barristars
·
2021-06-22
$Marathon Digital Holdings Inc(MARA)$
24 tonight?
看
2.67K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-19
like my comment
Largest Boeing 737 MAX model takes off on maiden flight
RENTON, Wash., June 18 (Reuters) - Boeing Co's 737 MAX 10, the largest member of its best-selling si
Largest Boeing 737 MAX model takes off on maiden flight
看
2.60K
回复
2
点赞
4
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-19
comment and like please
Sorry, this post has been deleted
看
2.90K
回复
2
点赞
5
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-18
$Uxin(UXIN)$
helpp
看
5.49K
回复
11
点赞
9
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-18
please like my post
Sorry, this post has been deleted
看
3.03K
回复
1
点赞
3
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-17
$Sonos Inc(SONO)$
hopefully...
看
3.54K
回复
2
点赞
1
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-17
this is a serious dip.
Musk-Touted CureVac Loses 49% of Value After Vaccine Setback
Company plunges After Covid Shot Falls Short With 47% Efficacy Effectiveness is far below that seen
Musk-Touted CureVac Loses 49% of Value After Vaccine Setback
看
2.37K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-17
$CureVac B.V.(CVAC)$
I'm shocked. beyond words
看
2.91K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-16
it's been like that for a while..
Sorry, this post has been deleted
看
2.72K
回复
1
点赞
1
编组 21备份 2
Share
Report
barristars
barristars
·
2021-06-15
$Naked Brand(NAKD)$
yup hold the line!!
看
2.32K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3578039067490924","uuid":"3578039067490924","gmtCreate":1614945043578,"gmtModify":1620018531814,"name":"barristars","pinyin":"barristars","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":38,"tweetSize":57,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":129982419,"gmtCreate":1624351595431,"gmtModify":1703834166087,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a>24 tonight?","listText":"<a href=\"https://laohu8.com/S/MARA\">$Marathon Digital Holdings Inc(MARA)$</a>24 tonight?","text":"$Marathon Digital Holdings Inc(MARA)$24 tonight?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129982419","isVote":1,"tweetType":1,"viewCount":2666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165010762,"gmtCreate":1624080233256,"gmtModify":1703828458164,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"like my comment","listText":"like my comment","text":"like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/165010762","repostId":"2144086770","repostType":4,"repost":{"id":"2144086770","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624062134,"share":"https://ttm.financial/m/news/2144086770?lang=&edition=fundamental","pubTime":"2021-06-19 08:22","market":"us","language":"en","title":"Largest Boeing 737 MAX model takes off on maiden flight","url":"https://stock-news.laohu8.com/highlight/detail?id=2144086770","media":"Reuters","summary":"RENTON, Wash., June 18 (Reuters) - Boeing Co's 737 MAX 10, the largest member of its best-selling si","content":"<p>RENTON, Wash., June 18 (Reuters) - Boeing Co's 737 MAX 10, the largest member of its best-selling single-aisle airplane family, took off on its maiden flight on Friday, in a further step toward recovering from the safety grounding of a smaller model.</p>\n<p>The plane completed a roughly 2-1/2-hour flight over Washington State, returning to Renton Municipal Airport near Seattle at 12:38 p.m.</p>\n<p>The first flight heralds months of testing and safety certification work before the jet is expected to enter service in 2023.</p>\n<p>In an unusual departure from the PR buzz surrounding first flights, the event was kept low-key as Boeing tries to navigate overlapping crises caused by a 20-month grounding in the wake of two crashes and the COVID-19 pandemic.</p>\n<p>Boeing's 230-seat 737-10 is designed to close the gap between its 178-to-220-seat 737-9, and Airbus's 185-to-240-seat A321neo, which dominates the top end of the narrowbody jet market, worth some $3.5 trillion over 20 years.</p>\n<p>However, the market opportunity for the 737 MAX 10 is constrained by the jet's range of about 3,300 nautical miles (6,100 km), which falls short of the A321neo's roughly 4,000 nm.</p>\n<p>Boeing must also complete safety certification of the plane under a tougher regulatory climate following two fatal crashes of a smaller 737 MAX version grounded the model for nearly two years - with a safety ban still in place in China.</p>\n<p>Boeing has carried out design and training changes on the MAX family, which returned to U.S. operations in December.</p>\n<p>Boeing Commercial Airplanes CEO Stan Deal said the company is producing about 16 737 MAX jets a month at its Renton factory.</p>\n<p>Boeing is working on safety enhancements for the 737 MAX 10, including for its air data indication system and adding a third cockpit indication requested by European regulators of the \"angle of attack,\" a parameter needed to avoid stalling or losing lift. Deal’s comments were provided to the media via a pool reporter inside a Boeing aircraft delivery center.</p>\n<p>\"We're going to take our time on this certification,\" Deal said.</p>\n<p>While the smaller MAX 8 is Boeing's fastest-selling jet, slow sales of the MAX 9 and 10 models have put Boeing at a disadvantage to the A321neo.</p>\n<p>Boeing has abandoned plans to tinker with the 737 MAX 10 design, but is weighing a bolder plan to replace the single-aisle 757, which overlaps with the top end of the MAX family.</p>\n<p>Even so, Boeing says it is confident in the MAX 10, and it is stepping up efforts to sell more of the jet, with key targets, including Ireland's Ryanair .</p>\n<p>Customers include United Airlines with 100 on order. Although sources say United is weighing a new order for at least 100 or even up to 200 MAX, its requirement for large single-aisles will be served by Airbus - reinforcing the market split.</p>\n<p>The flight, watched by dozens of employees but virtually no visitors as Boeing sought to downplay the event, showcased a revamped landing gear system illustrating an industry battle to squeeze as much mileage as possible out of the current generation of single-aisles.</p>\n<p>It raises the landing gear's height during take-off and landing, a design needed to compensate for the MAX 10's extra length and prevent the tail scraping the runway on take-off.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Largest Boeing 737 MAX model takes off on maiden flight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLargest Boeing 737 MAX model takes off on maiden flight\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-19 08:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>RENTON, Wash., June 18 (Reuters) - Boeing Co's 737 MAX 10, the largest member of its best-selling single-aisle airplane family, took off on its maiden flight on Friday, in a further step toward recovering from the safety grounding of a smaller model.</p>\n<p>The plane completed a roughly 2-1/2-hour flight over Washington State, returning to Renton Municipal Airport near Seattle at 12:38 p.m.</p>\n<p>The first flight heralds months of testing and safety certification work before the jet is expected to enter service in 2023.</p>\n<p>In an unusual departure from the PR buzz surrounding first flights, the event was kept low-key as Boeing tries to navigate overlapping crises caused by a 20-month grounding in the wake of two crashes and the COVID-19 pandemic.</p>\n<p>Boeing's 230-seat 737-10 is designed to close the gap between its 178-to-220-seat 737-9, and Airbus's 185-to-240-seat A321neo, which dominates the top end of the narrowbody jet market, worth some $3.5 trillion over 20 years.</p>\n<p>However, the market opportunity for the 737 MAX 10 is constrained by the jet's range of about 3,300 nautical miles (6,100 km), which falls short of the A321neo's roughly 4,000 nm.</p>\n<p>Boeing must also complete safety certification of the plane under a tougher regulatory climate following two fatal crashes of a smaller 737 MAX version grounded the model for nearly two years - with a safety ban still in place in China.</p>\n<p>Boeing has carried out design and training changes on the MAX family, which returned to U.S. operations in December.</p>\n<p>Boeing Commercial Airplanes CEO Stan Deal said the company is producing about 16 737 MAX jets a month at its Renton factory.</p>\n<p>Boeing is working on safety enhancements for the 737 MAX 10, including for its air data indication system and adding a third cockpit indication requested by European regulators of the \"angle of attack,\" a parameter needed to avoid stalling or losing lift. Deal’s comments were provided to the media via a pool reporter inside a Boeing aircraft delivery center.</p>\n<p>\"We're going to take our time on this certification,\" Deal said.</p>\n<p>While the smaller MAX 8 is Boeing's fastest-selling jet, slow sales of the MAX 9 and 10 models have put Boeing at a disadvantage to the A321neo.</p>\n<p>Boeing has abandoned plans to tinker with the 737 MAX 10 design, but is weighing a bolder plan to replace the single-aisle 757, which overlaps with the top end of the MAX family.</p>\n<p>Even so, Boeing says it is confident in the MAX 10, and it is stepping up efforts to sell more of the jet, with key targets, including Ireland's Ryanair .</p>\n<p>Customers include United Airlines with 100 on order. Although sources say United is weighing a new order for at least 100 or even up to 200 MAX, its requirement for large single-aisles will be served by Airbus - reinforcing the market split.</p>\n<p>The flight, watched by dozens of employees but virtually no visitors as Boeing sought to downplay the event, showcased a revamped landing gear system illustrating an industry battle to squeeze as much mileage as possible out of the current generation of single-aisles.</p>\n<p>It raises the landing gear's height during take-off and landing, a design needed to compensate for the MAX 10's extra length and prevent the tail scraping the runway on take-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144086770","content_text":"RENTON, Wash., June 18 (Reuters) - Boeing Co's 737 MAX 10, the largest member of its best-selling single-aisle airplane family, took off on its maiden flight on Friday, in a further step toward recovering from the safety grounding of a smaller model.\nThe plane completed a roughly 2-1/2-hour flight over Washington State, returning to Renton Municipal Airport near Seattle at 12:38 p.m.\nThe first flight heralds months of testing and safety certification work before the jet is expected to enter service in 2023.\nIn an unusual departure from the PR buzz surrounding first flights, the event was kept low-key as Boeing tries to navigate overlapping crises caused by a 20-month grounding in the wake of two crashes and the COVID-19 pandemic.\nBoeing's 230-seat 737-10 is designed to close the gap between its 178-to-220-seat 737-9, and Airbus's 185-to-240-seat A321neo, which dominates the top end of the narrowbody jet market, worth some $3.5 trillion over 20 years.\nHowever, the market opportunity for the 737 MAX 10 is constrained by the jet's range of about 3,300 nautical miles (6,100 km), which falls short of the A321neo's roughly 4,000 nm.\nBoeing must also complete safety certification of the plane under a tougher regulatory climate following two fatal crashes of a smaller 737 MAX version grounded the model for nearly two years - with a safety ban still in place in China.\nBoeing has carried out design and training changes on the MAX family, which returned to U.S. operations in December.\nBoeing Commercial Airplanes CEO Stan Deal said the company is producing about 16 737 MAX jets a month at its Renton factory.\nBoeing is working on safety enhancements for the 737 MAX 10, including for its air data indication system and adding a third cockpit indication requested by European regulators of the \"angle of attack,\" a parameter needed to avoid stalling or losing lift. Deal’s comments were provided to the media via a pool reporter inside a Boeing aircraft delivery center.\n\"We're going to take our time on this certification,\" Deal said.\nWhile the smaller MAX 8 is Boeing's fastest-selling jet, slow sales of the MAX 9 and 10 models have put Boeing at a disadvantage to the A321neo.\nBoeing has abandoned plans to tinker with the 737 MAX 10 design, but is weighing a bolder plan to replace the single-aisle 757, which overlaps with the top end of the MAX family.\nEven so, Boeing says it is confident in the MAX 10, and it is stepping up efforts to sell more of the jet, with key targets, including Ireland's Ryanair .\nCustomers include United Airlines with 100 on order. Although sources say United is weighing a new order for at least 100 or even up to 200 MAX, its requirement for large single-aisles will be served by Airbus - reinforcing the market split.\nThe flight, watched by dozens of employees but virtually no visitors as Boeing sought to downplay the event, showcased a revamped landing gear system illustrating an industry battle to squeeze as much mileage as possible out of the current generation of single-aisles.\nIt raises the landing gear's height during take-off and landing, a design needed to compensate for the MAX 10's extra length and prevent the tail scraping the runway on take-off.","news_type":1,"symbols_score_info":{"BA":0.9}},"isVote":1,"tweetType":1,"viewCount":2597,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162266054,"gmtCreate":1624065024178,"gmtModify":1703827927784,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"comment and like please","listText":"comment and like please","text":"comment and like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/162266054","repostId":"1156696708","repostType":4,"isVote":1,"tweetType":1,"viewCount":2904,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166574973,"gmtCreate":1624020449492,"gmtModify":1703826728170,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UXIN\">$Uxin(UXIN)$</a>helpp","listText":"<a href=\"https://laohu8.com/S/UXIN\">$Uxin(UXIN)$</a>helpp","text":"$Uxin(UXIN)$helpp","images":[{"img":"https://static.tigerbbs.com/070c98fa32e1cae0d44c38284579b5c6","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":9,"commentSize":11,"repostSize":0,"link":"https://ttm.financial/post/166574973","isVote":1,"tweetType":1,"viewCount":5488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":166529608,"gmtCreate":1624018893804,"gmtModify":1703826677164,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"please like my post","listText":"please like my post","text":"please like my post","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166529608","repostId":"2144775754","repostType":4,"isVote":1,"tweetType":1,"viewCount":3026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161148069,"gmtCreate":1623913704151,"gmtModify":1703823365622,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SONO\">$Sonos Inc(SONO)$</a>hopefully...","listText":"<a href=\"https://laohu8.com/S/SONO\">$Sonos Inc(SONO)$</a>hopefully...","text":"$Sonos Inc(SONO)$hopefully...","images":[{"img":"https://static.tigerbbs.com/6c75760d7d3a624ef50d7476e9aa097f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/161148069","isVote":1,"tweetType":1,"viewCount":3541,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578350332890873","authorId":"3578350332890873","name":"tseechu1","avatar":"https://static.tigerbbs.com/0c0f4d70e2e88f11bd9f8995165754be","crmLevel":11,"crmLevelSwitch":0,"idStr":"3578350332890873","authorIdStr":"3578350332890873"},"content":"It got to be. I'm higher then u [Spurting] [Spurting] [Spurting] [Spurting] [Spurting]","text":"It got to be. I'm higher then u [Spurting] [Spurting] [Spurting] [Spurting] [Spurting]","html":"It got to be. I'm higher then u [Spurting] [Spurting] [Spurting] [Spurting] [Spurting]"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":163754060,"gmtCreate":1623894470650,"gmtModify":1703822799105,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"this is a serious dip.","listText":"this is a serious dip.","text":"this is a serious dip.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163754060","repostId":"1199737134","repostType":4,"repost":{"id":"1199737134","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623885157,"share":"https://ttm.financial/m/news/1199737134?lang=&edition=fundamental","pubTime":"2021-06-17 07:12","market":"us","language":"en","title":"Musk-Touted CureVac Loses 49% of Value After Vaccine Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=1199737134","media":"Tiger Newspress","summary":"Company plunges After Covid Shot Falls Short With 47% Efficacy\nEffectiveness is far below that seen ","content":"<ul>\n <li>Company plunges After Covid Shot Falls Short With 47% Efficacy</li>\n <li>Effectiveness is far below that seen with other mRNA vaccines</li>\n</ul>\n<p>CureVac NV shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.</p>\n<p>The interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.</p>\n<p>Though preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.</p>\n<p>“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.</p>\n<p>The company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.</p>\n<p><img src=\"https://static.tigerbbs.com/d6ec3f2e05cfbc6c7d87c3fa174f459c\" tg-width=\"1302\" tg-height=\"663\"></p>\n<p>In April, Elon Musk tweeted about CureVac, which Tesla Inc. has partnered with on a vaccine printer,saying it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.</p>\n<p>The shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with Bayer AG,GlaxoSmithKline Plc and the U.K. government aimed at speeding production of its shot and future versions that will target mutated strains.</p>\n<p>The data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the more than 2.4 billion shots administered so far.</p>\n<p>The proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.</p>\n<p><b>Genetic Sequencing</b></p>\n<p>CureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.</p>\n<p>TheWorld Health Organization added lambda to its watchlist as a variant of interest on Monday.</p>\n<p>Some 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.</p>\n<p>That variant is now the most common in the U.S., and other vaccines, including shots from Pfizer Inc. and BioNTech SE as well as Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.</p>\n<p><b>Final Readout</b></p>\n<p>More details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.</p>\n<p>Like the shots from Moderna Inc. and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.</p>\n<p>CureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.</p>\n<p>CureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk-Touted CureVac Loses 49% of Value After Vaccine Setback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk-Touted CureVac Loses 49% of Value After Vaccine Setback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Company plunges After Covid Shot Falls Short With 47% Efficacy</li>\n <li>Effectiveness is far below that seen with other mRNA vaccines</li>\n</ul>\n<p>CureVac NV shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.</p>\n<p>The interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.</p>\n<p>Though preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.</p>\n<p>“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.</p>\n<p>The company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.</p>\n<p><img src=\"https://static.tigerbbs.com/d6ec3f2e05cfbc6c7d87c3fa174f459c\" tg-width=\"1302\" tg-height=\"663\"></p>\n<p>In April, Elon Musk tweeted about CureVac, which Tesla Inc. has partnered with on a vaccine printer,saying it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.</p>\n<p>The shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with Bayer AG,GlaxoSmithKline Plc and the U.K. government aimed at speeding production of its shot and future versions that will target mutated strains.</p>\n<p>The data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the more than 2.4 billion shots administered so far.</p>\n<p>The proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.</p>\n<p><b>Genetic Sequencing</b></p>\n<p>CureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.</p>\n<p>TheWorld Health Organization added lambda to its watchlist as a variant of interest on Monday.</p>\n<p>Some 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.</p>\n<p>That variant is now the most common in the U.S., and other vaccines, including shots from Pfizer Inc. and BioNTech SE as well as Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.</p>\n<p><b>Final Readout</b></p>\n<p>More details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.</p>\n<p>Like the shots from Moderna Inc. and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.</p>\n<p>CureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.</p>\n<p>CureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVAC":"CureVac B.V."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199737134","content_text":"Company plunges After Covid Shot Falls Short With 47% Efficacy\nEffectiveness is far below that seen with other mRNA vaccines\n\nCureVac NV shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.\nThe interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.\nThough preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.\n“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.\nThe company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.\n\nIn April, Elon Musk tweeted about CureVac, which Tesla Inc. has partnered with on a vaccine printer,saying it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.\nThe shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with Bayer AG,GlaxoSmithKline Plc and the U.K. government aimed at speeding production of its shot and future versions that will target mutated strains.\nThe data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the more than 2.4 billion shots administered so far.\nThe proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.\nGenetic Sequencing\nCureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.\nTheWorld Health Organization added lambda to its watchlist as a variant of interest on Monday.\nSome 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.\nThat variant is now the most common in the U.S., and other vaccines, including shots from Pfizer Inc. and BioNTech SE as well as Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.\nFinal Readout\nMore details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.\nLike the shots from Moderna Inc. and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.\nCureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.\nCureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.","news_type":1,"symbols_score_info":{"CVAC":0.9}},"isVote":1,"tweetType":1,"viewCount":2369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163750017,"gmtCreate":1623894266839,"gmtModify":1703822787547,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CVAC\">$CureVac B.V.(CVAC)$</a>I'm shocked. beyond words","listText":"<a href=\"https://laohu8.com/S/CVAC\">$CureVac B.V.(CVAC)$</a>I'm shocked. beyond words","text":"$CureVac B.V.(CVAC)$I'm shocked. beyond words","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163750017","isVote":1,"tweetType":1,"viewCount":2905,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169413153,"gmtCreate":1623846977172,"gmtModify":1703821216280,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"it's been like that for a while..","listText":"it's been like that for a while..","text":"it's been like that for a while..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/169413153","repostId":"2143897767","repostType":4,"isVote":1,"tweetType":1,"viewCount":2717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187657596,"gmtCreate":1623753280715,"gmtModify":1704210552306,"author":{"id":"3578039067490924","authorId":"3578039067490924","name":"barristars","avatar":"https://static.tigerbbs.com/990f0ecdc28a9a87d4b6e6712697972d","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578039067490924","authorIdStr":"3578039067490924"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>yup hold the line!!","listText":"<a href=\"https://laohu8.com/S/NAKD\">$Naked Brand(NAKD)$</a>yup hold the line!!","text":"$Naked Brand(NAKD)$yup hold the line!!","images":[{"img":"https://static.tigerbbs.com/28c1f6990d1e30a3a5b231bed7406957","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187657596","isVote":1,"tweetType":1,"viewCount":2319,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}